All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Compounded Medication Labeling Requirements Explained

When your compounded medication arrives, the label on that vial tells you a lot about the pharmacy behind it.

By FormBlends Editorial Research||
In This Article

This article is part of our Peptide Therapy collection. See also: GLP-1 Guides | Provider Comparisons

Key Takeaway

See your personalized options in about 2 minutes. Free and private. See my options →

When your compounded medication arrives, the label on that vial tells you a lot about the pharmacy behind it. Understanding compounded medication labeling requirements helps you verify that your medication is legitimate, properly prepared, and safe to use.

When your compounded medication arrives, the label on that vial tells you a lot about the pharmacy behind it. Understanding compounded medication labeling requirements helps you verify that your medication is legitimate, properly prepared, and safe to use.

Key Takeaways: - Required Label Elements for Compounded Medications - Understand what each label element tells you about quality - Common Labeling Problems and What They Mean - Learn how to read your glp-1 medication label

This guide walks you through every element that should be on your compounded medication label and what to do if something is missing.

Required Label Elements for Compounded Medications

State boards of pharmacy and USP standards require specific information on every compounded medication label. While exact requirements vary slightly by state, the core elements are consistent.

Patient name. Your name should appear on the label. This confirms the medication was compounded for you specifically, based on your provider's prescription. If your name isn't on the label, that's a problem.

Prescriber name. The name of the healthcare provider who wrote your prescription should be listed. This creates a chain of accountability from provider to pharmacy to patient.

Drug name and strength. The label must clearly state the active ingredient and its concentration or strength. For example, "Semaglutide 5mg/mL" tells you exactly what's in the vial and how much per milliliter.

Quantity. The total volume or quantity of medication in the container. This might read "2mL" or "5mL" for an injectable vial.

Beyond-use date (BUD). This is the date after which the medication shouldn't be used. It's different from a manufacturer's expiration date. Compounded medications typically have shorter beyond-use dates because they're prepared in smaller batches. Never use a compounded medication past this date.

"What makes tirzepatide particularly interesting is the dual GIP/GLP-1 mechanism. We're seeing that GIP receptor activation appears to amplify the metabolic effects in ways we didn't fully anticipate from the preclinical data.") Dr. Ania Jastreboff, MD, PhD, Yale School of Medicine, lead author of SURMOUNT-1[1]

Storage instructions. Your label should tell you how to store the medication. Most compounded injectables, including , require refrigeration.

Pharmacy name and address. The licensed compounding pharmacy's name and physical address must appear on the label. This lets you verify the pharmacy's licensing status.

What Each Label Element Tells You About Quality

The label isn't just a legal requirement (it's a quality indicator. Here's what to read between the lines.

Compounded Medication Labeling Requirements Explained: scientist in glasses examines vials with blue caps in a lab

A complete label signals compliance. If every required element is present, clearly printed, and accurate, it suggests the pharmacy follows established protocols. Sloppy or incomplete labeling often correlates with sloppy compounding practices.

The beyond-use date tells you about testing. Pharmacies that perform stability testing can assign longer beyond-use dates. A very short BUD (a few days) on a product that should be stable longer might indicate the pharmacy hasn't done stability testing. A BUD that seems excessively long might indicate the pharmacy is assigning dates without supporting data.

Concentration formatting matters. The strength should be expressed in standard pharmaceutical notation) mg/mL for injectables, for example. Unusual or ambiguous strength descriptions can indicate a lack of pharmaceutical expertise.

Lot or batch numbers enable traceability. While not required in every state, lot numbers allow the pharmacy to trace your medication back to specific ingredient batches and preparation records. If a problem is discovered later, this number is how they track which patients were affected.

If you're managing a , proper labeling helps you keep track of exactly what you're using and when it expires.


Free Download: Compounding Pharmacy Verification Checklist This printable checklist includes a label verification section you can use to check every medication you receive. Get yours free (we'll email it to you instantly. [Email Input] [Download Button]


Common Labeling Problems and What They Mean

Not all labeling issues are equally serious. Here's how to evaluate common problems.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Missing patient name. This could mean the medication wasn't prepared for you specifically. Under 503A compounding rules, medications must be patient-specific. A missing name raises questions about whether a valid prescription was involved.

No beyond-use date. This is a significant safety concern. Without a BUD, you have no way to know if the medication has degraded. Degraded medications may be less effective or potentially harmful. Don't use a compounded medication without a beyond-use date.

Vague strength information. If the label says something like "semaglutide solution" without a specific concentration, you can't verify your dose. This is both a safety issue and a sign of poor pharmacy practices.

No pharmacy information. If there's no pharmacy name or address on the label, you can't verify the source. This is a major red flag. Legitimate pharmacies are proud to put their name on their work.

Handwritten labels. While not automatically disqualifying, handwritten labels on injectable medications are unusual for established compounding pharmacies. Most use professional label printing systems. Handwriting increases the risk of errors and is harder to read.

Misspellings or errors. Spelling mistakes on a pharmaceutical label indicate a lack of quality controls. If the pharmacy doesn't catch errors on the label, what else are they missing?

If you receive a medication with any of these issues, contact the pharmacy and your prescribing provider before using it. You can also to discuss your concerns.

How to Read Your GLP-1 Medication Label

Let's walk through a practical example of reading a compounded GLP-1 medication label.

A properly labeled vial of compounded semaglutide should include:

  • Your name) confirms it was prescribed for you
  • "Semaglutide [X] mg/mL", the active ingredient and its concentration per milliliter
  • Total volume, such as "2 mL", tells you how much is in the vial
  • "Subcutaneous injection", the route of administration
  • Beyond-use date, the last date you should use this medication
  • "Store refrigerated 2-8°C", or similar storage instructions
  • Pharmacy name, address, and phone number, who made it
  • Prescriber name, who prescribed it
  • Lot number, for traceability
  • "Rx Only", confirms it's a prescription medication

Some labels also include auxiliary warnings like "Protect from light" or "Shake gently before use" if applicable to the formulation.

Understanding your label helps you use your medication safely and gives you confidence in its source. For help tracking your doses and protocol, try the , it logs doses, visualizes medication levels, and keeps your treatment organized.

What's the difference between a beyond-use date and an expiration date?

An expiration date applies to commercially manufactured medications and is based on extensive stability testing. A beyond-use date (BUD) applies to compounded medications and indicates when the preparation should no longer be used. BUDs are typically shorter than expiration dates and are determined based on USP guidelines and the pharmacy's stability data.

Should my compounded medication have a lot number?

While not required in all states, lot numbers are a best practice. They enable the pharmacy to trace your medication back to specific ingredients and preparation records. Pharmacies that assign lot numbers typically have more well-tested quality systems.

Can I request a new label if mine is damaged or hard to read?

Yes. Contact your compounding pharmacy and ask for a replacement label. A damaged or illegible label is a safety concern because you may not be able to read critical information like the beyond-use date or concentration. Don't use a medication with an unreadable label.

What should I do if my label information doesn't match my prescription?

Don't use the medication. Contact the pharmacy immediately to resolve the discrepancy. Also notify your prescribing provider. A mismatch between your prescription and the medication label could indicate a dispensing error.

Are labeling requirements the same in every state?

Core labeling requirements are similar across states, but specific requirements can vary. Some states require additional information such as the date dispensed, number of refills remaining, or specific auxiliary warnings. Your state board of pharmacy's regulations define the exact requirements for your state.

Your treatment plan is personal (and you deserve a plan that fits. FormBlends connects you with licensed providers who can evaluate your needs and create a personalized protocol.


  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
  2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
  3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
  4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

  1. Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections) United States, 2012. MMWR. 2012;61(41):839-842.
  2. U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
  4. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
  5. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
  6. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
  7. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563

Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.

Last updated: 2026-03-24

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Compounded Medication Labeling Requirements Explained
FormBlends guide cover for Compounded Medication Labeling Requirements Explained.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

Peptide decision path

Move from research interest to supervised review

Related treatment context

Compounded Medication Labeling Requirements Explained should be evaluated through research status, legal access, source quality, safety context, and clinician oversight rather than a shortcut purchase decision.

Evidence check

Useful peptide pages should separate human data, animal research, mechanistic evidence, and marketing claims.

Safety check

Peptides can vary by legal status, compounding pathway, purity testing, patient history, and interaction risk.

Next step

Compare available peptide options and their evidence before choosing a plan. Each available prescription requires provider review.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify the pharmacy pathway, certificate of analysis, sterility testing, and clinician oversight before trusting a source.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Download the Peptide Quick Reference Card

A printable 2-page reference covering popular peptides, dosing ranges, stacking protocols, and storage.

Free download. We'll also send helpful GLP-1 guides to your inbox. Unsubscribe anytime.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

Patient Experience

GLP-1 Drug Labeling Changes: Complete History

GLP-1 Drug Labeling Changes: Complete History: patient experience guidance on patient experience, with safety context, decision points, and practical...

GLP-1 Weight Loss

The Complete GLP-1 List: Every FDA-Approved and Compounded Medication for Weight Loss and Diabetes in 2026

Every FDA-approved GLP-1 medication and compounded option for weight loss and diabetes, with dosing, pricing, availability, and what each one does best.

GLP-1 Weight Loss

Tirzepatide Discount Card: Why Most Don't Work for Compounded Medication (and What Actually Saves You Money)

Why manufacturer discount cards don't work for compounded tirzepatide, which programs actually reduce costs, and the real per-dose price comparison.

Peptide Therapy

How Long Does Compounded Tirzepatide Actually Last? The Expiration Date Decoder

Compounded tirzepatide expires 30-90 days after dispensing, not the date on the vial. Learn what determines real stability and when to discard safely.

Peptide Therapy

How to Get Compounded Tirzepatide: The Complete Step-by-Step Process for 2026

Step-by-step process to access compounded tirzepatide: telehealth consult, prescription requirements, pharmacy selection, and what to expect at each step.

Peptide Therapy

Understanding Beyond Use Dating For Compounded Meds

Beyond-use dating for compounded medication tells you how long your medication is safe and effective to use. This beyond-use dating compounded medication resource covers the essential information you need to make informed decisions.

Peptide Therapy

How Long Is Compounded Tirzepatide Good For After You Receive It?

Compounded tirzepatide lasts 28-60 days refrigerated depending on formulation. A complete guide to expiration dates, storage, and when to discard.

Peptide Therapy

C-Peptide vs Insulin Level: Which Test Tells You More? | FormBlends

C-peptide vs insulin level compared: what each test measures, when clinicians order one over the other, evidence grades, and how to read your own results.

Peptide Therapy

Does Compounded Tirzepatide Expire? The Complete Shelf Life and Storage Timeline

Compounded tirzepatide expires 30-90 days after reconstitution. A complete guide to beyond-use dates, storage rules, and when expired medication fails.

FormBlends for iPhone

Reconstitution math, dose schedules and logs in one place

The free FormBlends iPhone app keeps peptide schedules, concentrations, reminders, inventory and progress notes together.

Free Tools

Calculators to support your weight loss journey.